Ind-Swift Laboratories Limited (NSE:INDSWFTLAB)
India · Delayed Price · Currency is INR 391.10
-9.35 (-2.33%)
Oct 7, 2026, 3:29 PM IST
Ind-Swift Laboratories Market Cap
Ind-Swift Laboratories has a market cap or net worth of 34.01 billion as of October 7, 2026. That makes Ind-Swift Laboratories the world's 17,370th most valuable company and 1,021st in India. Its market cap has increased by 309.73% in one year.
Market Cap
34.01B
Enterprise Value
29.80B
Revenue
6.74B
Global Rank
Country Rank
#1,021 India
PE Ratio
61.86
ChartMarket Cap Chart
Since June 1, 1999, Ind-Swift Laboratories's market cap has increased from 111.51M to 34.01B, an increase of 30,399.03%. That is a compound annual growth rate of 23.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 34.01B | 372.76% |
| Dec 31, 2025 | 7.19B | 12.14% |
| Dec 31, 2024 | 6.42B | 4.85% |
| Dec 29, 2023 | 6.12B | 49.10% |
| Dec 30, 2022 | 4.10B | 2.21% |
| Dec 31, 2021 | 4.01B | 9.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 66.74B |
| Sun Pharma Advanced Research Company | 63.86B |
| Orchid Pharma | 51.93B |
| RPG Life Sciences | 47.84B |
| Solara Active Pharma Sciences | 32.99B |
| Indoco Remedies | 22.76B |
| Sakar Healthcare | 22.70B |
| Windlas Biotech | 21.09B |